Skip to main content
. 2025 May 6;13(5):1128. doi: 10.3390/biomedicines13051128
IBD Inflammatory Bowel Disease
CD Crohn’s Disease
UC Ulcerative colitis
PsO Psoriasis
GLP-1 Glucagon-like peptide-1
GLP-1RA Glucagon-like peptide-1 receptor agonist
IMID Immune Mediated Inflammatory Disease
cAMP cyclic adenosine monophosphate
IEL intra epithelial lymphocytes
CSMCs colon smooth muscle cells
ILC3 Group 2 innate lymphoid cells
PKA protein kinase A
NFκB Nuclear factor kappa beta
DSS Dextran Sodium sulphate
Ex-4 Exendin-4
RT-qPCR Real time quantitative (reverse transcriptase) polymerase chain reaction
CRP C-reactive protein
LDH lactate dehydrogenase
LPS lipopolysaccharide
CREB cAMP response element binding protein
TCR T cell receptor
AdTr adoptive transfer
DMS N, N-dimethyl sphingosine
S1P sphingosine-1-phosphate
LTβR Lymphotoxin beta receptor
ELISA enzyme linked immunosorbent assay
ClpB Caseinolytic protease B
SNS suppresses sympathetic nervous system
NE norepinephrine
BT bacterial translocation
TAC total antioxidant capacity
SOD superoxide dismutase
GSH glutathione
MDA malondialdehyde
T2DM Type 2 Diabetes Mellitus
AOMs anti-obesity medications
aOR adjusted odds ratio
RA rheumatoid arthritis
FLS fibroblast-like synoviocytes
BMI Body Mass Index
PsA Psoriatic Arthritis
RCT randomized controlled trial
PASI Psoriasis Area Severity Index
DLQI Dermatology Life Quality Index
iNKT cells invariant natural killer T cells